Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis

被引:25
作者
Wu, Xinle [1 ]
Li, Yang [1 ]
机构
[1] Amgen Inc, 1120 Vet Blvd, San Francisco, CA 94080 USA
来源
AGING-US | 2009年 / 1卷 / 12期
关键词
fibroblast growth factors; FGF19; FGF21; FGF23; aging; diabetes; metabolic diseases; insulin; METABOLIC-ACTIVITY; BETA-KLOTHO; GROWTH; SPECIFICITY; SUPPRESSION; DETERMINES; EXPRESSION; SIGNAL; FAMILY; MODE;
D O I
10.18632/aging.100108
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
FGF19, FGF21, and FGF23 form a unique subfamily of fibroblast growth factors. Because they contain intra molecular disulfide bonds and show reduced affinity toward heparan sulfate located in the extracellular space, it is thought that, in contrast to other FGFs, they function as endocrine hormones. FGF23 and its co-receptor alpha Klotho are involved in the control of aging, but it is not known if the same holds true for FGF19, which can also signal through alpha Klotho. However, considerable evidence supports a role for FGF19 in controlling various aspects of metabolism. We have recently fully characterized FGF19/FGFR/co-factor interactions and signaling, and in the current manuscript discuss the contribution of the FGF19/FGFR4 axis to bile acid and glucose regulation.
引用
收藏
页码:1023 / 1027
页数:5
相关论文
共 50 条
  • [21] Developmental regulation of the intestinal FGF19 system in domestic pigs
    Gavalda-Navarro, Aleix
    Pastor, Jose J.
    Mereu, Alessandro
    Villarroya, Francesc
    Ipharraguerre, Ignacio R.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2018, 314 (06): : G647 - G654
  • [22] FGFR4 in endocrine resistance: overexpression and estrogen regulation without direct causative role
    Ding, Kai
    Chen, Lyuqin
    Levine, Kevin M.
    Sikora, Matthew J.
    Tasdemir, Nilgun
    Dabbs, David
    Jankowitz, Rachel
    Hazan, Rachel
    Shah, Osama
    Atkinson, Jenny
    Lee, Adrian V.
    Oesterreich, Steffi
    BREAST CANCER RESEARCH AND TREATMENT, 2025, : 501 - 515
  • [23] The role of ghrelin in the regulation of glucose homeostasis
    Alamri, Bader N.
    Shin, Kyungsoo
    Chappe, Valerie
    Anini, Younes
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2016, 26 (01) : 3 - 11
  • [24] Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression
    Liu, Yanan
    Cao, Meng
    Cai, Yuepiao
    Li, Xiaokun
    Zhao, Chengguang
    Cui, Ri
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [25] FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer
    Xu, Min
    Chen, Shuzheng
    Yang, Weibin
    Cheng, Xue
    Ye, Yani
    Mao, Jianting
    Wu, Xulu
    Huang, Li
    Ji, Jiansong
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (01) : 151 - 160
  • [26] FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia
    Lan, Tian
    Morgan, Donald A.
    Rahmouni, Kamal
    Sonoda, Junichiro
    Fu, Xiaorong
    Burgess, Shawn C.
    Holland, William L.
    Kliewer, Steven A.
    Mangelsdorf, David J.
    CELL METABOLISM, 2017, 26 (05) : 709 - +
  • [27] Melatonin Suppresses Oral Squamous Cell Carcinomas Migration and Invasion through Blocking FGF19/FGFR 4 Signaling Pathway
    Wang, Leilei
    Su, Yuxiong
    Choi, Wing Shan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (18)
  • [28] FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4-GSK3β-Nrf2 Signaling
    Teng, Yong
    Zhao, Huakan
    Gao, Lixia
    Zhang, Wenfa
    Shull, Austin Y.
    Shay, Chloe
    CANCER RESEARCH, 2017, 77 (22) : 6215 - 6225
  • [29] H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma
    Joshi, Jaya Julie
    Coffey, Heather
    Corcoran, Erik
    Tsai, Jennifer
    Huang, Chia-Ling
    Ichikawa, Kana
    Prajapati, Sudeep
    Hao, Ming-Hong
    Bailey, Suzanna
    Wu, Jeremy
    Rimkunas, Victoria
    Karr, Craig
    Subramanian, Vanitha
    Kumar, Pavan
    MacKenzie, Crystal
    Hurley, Raelene
    Satoh, Takashi
    Yu, Kun
    Park, Eunice
    Rioux, Nathalie
    Kim, Amy
    Lai, Weidong G.
    Yu, Lihua
    Zhu, Ping
    Buonamici, Silvia
    Larsen, Nicholas
    Fekkes, Peter
    Wang, John
    Warmuth, Markus
    Reynolds, Dominic J.
    Smith, Peter G.
    Selvaraj, Anand
    CANCER RESEARCH, 2017, 77 (24) : 6999 - 7013
  • [30] Targeted inhibition of FGF19/FGFR cascade improves antitumor immunity and response rate in hepatocellular carcinoma
    Tai, David Wai Meng
    Le, Thi Bich Uyen
    Prawira, Aldo
    Ho, Rebecca Zhi Wen
    Huynh, Hung
    HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1236 - 1246